Enhancements    

Featured awards of Marc Cox

PHASE II OF BUILDING SCHOLARS - TRAINING CORE
Start Date: 7-1-2019
End Date: 6-30-2024
Sponsor: NIH - NATL INST OF GEN MEDICAL SCIENCES

PHASE II OF BUILDING SCHOLARS - RESEARCH ENRICHMENT CORE
Start Date: 7-1-2019
End Date: 6-30-2024
Sponsor: NIH - NATL INST OF GEN MEDICAL SCIENCES

PHASE II OF BUILDING SCHOLARS - INSTITUTIONAL DEVELOPMENT CORE
Start Date: 7-1-2019
End Date: 6-30-2024
Sponsor: NIH - NATL INST OF GEN MEDICAL SCIENCES

PHASE II OF BUILDING SCHOLARS - ADMINISTRATIVE CORE
Start Date: 7-1-2019
End Date: 6-30-2024
Sponsor: NIH - NATL INST OF GEN MEDICAL SCIENCES

PROOF-OF-CONCEPT STUDY OF SURFACE-DIRECTED AR INHIBITORS FOR THE TREATMENT OF PROSTATE CANCER
Start Date: 4-1-2019
End Date: 3-31-2020
Sponsor: LIZANELL AND COLBERT COLDWELL FOUNDATION

IDENTIFICATION OF A LEAD GMC1 FAMILY COMPOUND FOR THE TREATMENT OF PROSTATE CANCER
Start Date: 11-15-2018
End Date: 11-14-2019
Sponsor: MAIA BIOTECHNOLOGY

IDENTIFICATION OF A LEAD MJC13 FAMILY COMPOUND FOR THE TREATMENT OF PROSTATE CANCER
Start Date: 1-1-2019
End Date: 12-31-2019
Sponsor: MAIA BIOTECHNOLOGY

R13: SOCIETY FOR BASIC UROLOGIC RESEARCH ANNUAL MEETING: PRECISION MEDICINE IN UROLOGY: MOLECULAR MECHANISMS, DIAGNOSTICS AND THERAPEUTIC TARGETS
Start Date: 10-29-2018
End Date: 10-28-2019
Sponsor: NIH - NATIONAL CANCER INSTITUTE

A NOVEL APPROACH TO TREATING CASTRATION RESISTANT PROSTATE CANCER
Start Date: 6-1-2018
End Date: 1-31-2019
Sponsor: LIZANELL AND COLBERT COLDWELL FOUNDATION

DIRECT TARGETING OF THE FKBP52 COCHAPERONE FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER
Start Date: 7-1-2017
End Date: 6-30-2020
Sponsor: CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAM